M. Kelley

发表

Characterization of cholyl-leu-val-phe-phe-ala-OH as an inhibitor of amyloid beta-peptide polymerization

M. Findeis, S. Molineaux, W. Kubasek, 2001, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Modified-peptide inhibitors of amyloid beta-peptide polymerization.

M. Findeis, S. Molineaux, C. Arico-Muendel, 1999, Biochemistry.

The effect of pretreatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic metabolism of 2,4,5-trichlorophenoxyacetate (2,4,5-T) and 2,4-dichlorophenoxyacetate (2,4,-D).

M. Kelley, D. Vessey, 1987, Toxicology and applied pharmacology.

Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia.

J. Karliner, M. Kelley, Luyi Li, 2008, Biochemical and biophysical research communications.

Purification and partial sequencing of the XL-I form of xenobiotic-metabolizing medium chain fatty acid:CoA ligase from bovine liver mitochondria, and its homology with the essential hypertension protein.

M. Kelley, D. Vessey, 1997, Biochimica et biophysica acta.

Sphingosine protects aging hearts from ischemia/reperfusion injury

Yong Huang, M. Kelley, Luyi Li, 2009, Oxidative medicine and cellular longevity.

A Sphingosine Kinase Form 2 Knockout Sensitizes Mouse Myocardium to Ischemia/Reoxygenation Injury and Diminishes Responsiveness to Ischemic Preconditioning

J. Karliner, N. Honbo, Zhu-qiu Jin, 2011, Oxidative medicine and cellular longevity.

Dimethylsphingosine and FTY720 inhibit the SK1 form but activate the SK2 form of sphingosine kinase from rat heart

J. Karliner, R. Tao, M. Kelley, 2007, Journal of biochemical and molecular toxicology.

Lipopolysaccharide ( LPS )-binding Protein Accelerates the Binding o f LPS to CD 14 By

M. Wurfel, H. Lichenstein, David A. Johnson, 2003 .

Sphingosine can pre‐ and post‐condition heart and utilizes a different mechanism from sphingosine 1‐phosphate

J. Karliner, M. Kelley, Luyi Li, 2008, Journal of biochemical and molecular toxicology.

Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury.

J. Karliner, Yong Huang, B. Zhu, 2006, Medical science monitor : international medical journal of experimental and clinical research.

Isolation and sequencing of cDNAs for the XL‐I and XL‐III forms of bovine liver xenobiotic‐metabolizing medium‐chain fatty acid:CoA ligase

M. Kelley, D. Vessey, E. Lau, 2000, Journal of biochemical and molecular toxicology.

Isolation, sequencing, and expression of a cDNA for the HXM‐A form of xenobiotic/medium‐chain fatty acid:CoA ligase from human liver mitochondria

R. Warren, M. Kelley, D. Vessey, 2003, Journal of biochemical and molecular toxicology.

Interactions between a viral protease and cystatins.

B. Lenarčič, V. Turk, T. Towatari, 1988, Biological chemistry Hoppe-Seyler.

Modulation of the number of ligand binding sites of UDP-glucuronyltransferase by the gel to liquid-crystal phase transition of phosphatidylcholines.

D. Zakim, M. Kelley, Y. Hochman, 1983, The Journal of biological chemistry.

Characterization of the acyl-CoA:amino acid N-acyltransferases from primate liver mitochondria.

M. Kelley, D. Vessey, 1994, Journal of biochemical toxicology.

Characterization of triacsin C inhibition of short‐, medium‐, and long‐chain fatty acid:CoA ligases of human liver

R. Warren, M. Kelley, D. Vessey, 2004, Journal of biochemical and molecular toxicology.

A coupled assay for bile acid:CoA ligase.

M. Kelley, D. Vessey, A. Erdman, 1991, Analytical biochemistry.

The effects of ions on the conjugation of xenobiotics by the aralkyl-CoA and arylacetyl-CoA N-acyltransferases from bovine liver mitochondria.

M. Kelley, D. Vessey, 1990, Journal of biochemical toxicology.

Interaction of salicylate and ibuprofen with the carboxylic acid: CoA ligases from bovine liver mitochondria.

D A Vessey, J Hu, M Kelley, 1996, Journal of biochemical toxicology.

Structural comparison between the mitochondrial aralkyl-CoA and arylacetyl-CoA N-acyltransferases.

M. Kelley, D. Vessey, 1992, The Biochemical journal.

P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels.

M. Kelley, Luyi Li, D. Vessey, 2011, American journal of physiology. Heart and circulatory physiology.

P 2 X 7 receptor agonists pre-and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1 / P 2 X 7 channels

M. Kelley, Luyi Li, D. Vessey, 2011 .

Ischemic preconditioning requires opening of pannexin-1/P2X7 channels not only during preconditioning but again after index ischemia at full reperfusion

M. Kelley, Luyi Li, D. Vessey, 2011, Molecular and Cellular Biochemistry.

Dual role of divalent cations in the bile acid:CoA ligase catalyzed reaction.

M. Kelley, D. Vessey, 1994, Biochimica et biophysica acta.

A rapid radioassay for sphingosine kinase.

J. Karliner, M. Kelley, D. Vessey, 2005, Analytical biochemistry.

Isolation and characterization of mitochondrial acyl-CoA: glycine N-acyltransferases from kidney.

M. Kelley, D. Vessey, 1993, Journal of biochemical toxicology.

Interaction of 2,4-dichlorophenoxyacetate (2,4-D) and 2,4,5-trichlorophenoxyacetate (2,4,5-T) with the acyl-CoA: amino acid N-acyltransferase enzymes of bovine liver mitochondria.

M. Kelley, D. Vessey, 1986, Biochemical pharmacology.

Pannexin-I/P2X 7 Purinergic Receptor Channels Mediate the Release of Cardioprotectants Induced by Ischemic Pre- and Postconditioning

M. Kelley, Luyi Li, D. Vessey, 2010, Journal of cardiovascular pharmacology and therapeutics.

Techniques for Measuring the Activity of Carboxylic Acid:CoA Ligase and Acyl‐CoA:Amino Acid N‐Acyltransferase: The Amino Acid Conjugation Pathway

M. Kelley, D. Vessey, 2002, Current Protocols in Toxicology.

Characterization of the CoA ligases of human liver mitochondria catalyzing the activation of short- and medium-chain fatty acids and xenobiotic carboxylic acids.

R. Warren, M. Kelley, D. Vessey, 1999, Biochimica et biophysica acta.

Characterization of the monovalent and divalent cation requirements for the xenobiotic carboxylic acid: CoA ligases of bovine liver mitochondria.

M. Kelley, D. Vessey, 1998, Biochimica et biophysica acta.

Characterization of the reaction mechanism for the XL-I form of bovine liver xenobiotic/medium-chain fatty acid:CoA ligase.

M. Kelley, D. Vessey, 2001, The Biochemical journal.

Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14

M. Wurfel, D. Johnson, M. Kelley, 1994, The Journal of experimental medicine.

Inhibition of bile acid conjugation by cyclosporin A.

M. Kelley, D. Vessey, 1995, Biochimica et biophysica acta.

Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14

M. Wurfel, H. Lichenstein, David A. Johnson, 1994, The Journal of experimental medicine.

Determination of the mechanism of reaction for bile acid: CoA ligase.

M. Kelley, D. Vessey, 1994, The Biochemical journal.

Development of a radiolabeled ATP assay for carboxylic acid:CoA Ligases and its use in the characterization of the xenobiotic carboxylic acid:CoA ligases of bovine liver mitochondria

M. Kelley, D. Vessey, E. Lau, 1998, Journal of biochemical and molecular toxicology.